NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2020 it was $11.91M, down 64.3% from the year before. The highest annual figure on record is $33.35M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $11.91M | -64.3% |
| FY2019 | Dec 31, 2019 | $33.35M | +29.1% |
| FY2018 | Dec 31, 2018 | $25.84M | +39.7% |
| FY2017 | Dec 31, 2017 | $18.50M | +2.2% |
| FY2016 | Dec 31, 2016 | $18.09M | +1552.2% |
| FY2015 | Dec 31, 2015 | $1.10M | -85.5% |
| FY2014 | Dec 31, 2014 | $7.56M | +2.7% |
| FY2013 | Dec 31, 2013 | $7.36M | +51.9% |
| FY2012 | Dec 31, 2012 | $4.85M | – |
See a number that looks wrong?